Urgent Medication Assessment Required for Suspected Neuroleptic Malignant Syndrome
**Demographics:** - **Age:** 50 years - **Gender:** Male - **Location:** Georgia (country) - **Ethnicity:** Caucasian - **Health Conditions:** Paranoid schizophrenia diagnosed at 18, liver cirrhosis for the past seven years, history of treated Hepatitis C - **Recent habits:** Abandoned smoking and drinking after a stroke ## Medical Background **Chronic Issues:** - Living with paranoid schizophrenia for more than three decades treated consistently with antipsychotic medications. - Liver cirrhosis diagnosed approximately seven years ago after overcoming Hepatitis C. **Recent Medical History:** - Experienced a transient ischemic attack (TIA) about one and a half months ago, requiring a short hospital stay. - Following a stroke six days post-TIA, patient suffered from weakness, slurred speech, and issues with balance. - During the stroke, blood pressure peaked at 170-180 mmHg, with a loss of consciousness noted. - Spent 12 days in the hospital before returning home. - Noticed symptoms of muscle twitching and nerve tightness two weeks later. - Introduction of new drugs from a neurologist approximately 20 days ago; notable symptoms began 2-3 days prior, including episodes resembling "freezing" and periods of semi-consciousness. ## Current Symptoms **Primary concern:** - For the past 2-3 days, the patient has appeared semi-conscious, exhibiting extreme drowsiness yet able to respond to questions, despite delays. - Family members describe the patient's appearance as resembling someone under the influence of substances. - Prior episodes included unresponsive states marked by closed mouth and vacant stare lasting 1-2 minutes. **Additional symptoms:** - Imbalance and gait issues, difficulty in walking. - Blood pressure recorded at 150/90 mmHg, higher than his usual 120/80 mmHg. - Increased anxiety levels noted, particularly following the stroke. - Recently had nausea after eating an apple, resulting in an ER visit. - Currently no signs of fever or muscle rigidity as he is too somnolent for proper assessment. ## Laboratory Findings (August 7, 2025) - **ALT:** 21.7 - **AST:** 45.5 - **Gamma-GT:** 158.1 - **Total Cholesterol:** 3.47 - **Triglycerides:** 1.79 - **HDL-C:** 1.47 - **LDL-C:** 1.78 - **AST/ALT ratio:** 2.1 ## Recent MRI Insights - No acute anomalies detected; findings revealed: - Multiple lacunar changes in bilateral hemispheres and left pons. - Presence of leukoaraiosis. - Generalized cortical atrophy. - “Empty sella” condition noted. - No signs of aneurysm in MR angiography. ## Medications Overview **Medications prescribed prior to the stroke:** - Risperidone 4mg: Two tablets daily post meals. - Neurolepsin 400mg: One tablet once a day after meals. - Zopine (Zopiclone): Half tablet at bedtime. - Fluphenazine decanoate injection 25mg/ml: 1ml IM monthly. - Zolomax 0.5mg: As needed for anxiety (30-day supply). **Post-stroke medication regimen (from 1.5 months ago):** - Nexium 40mg: Daily before meals. - Enap 20mg: Once daily (later transitioned to Nolipril Forte). - Sorvasta 20mg: Once every evening after meals (for 2 months). - Plavix 75mg: Once daily for 1 month. - Aspirin Cardio 100mg: Once daily post-lunch. - Physiotens 0.4mg: As needed for elevated blood pressure (>150 mmHg). **Medications added by a new neurologist (20 days ago):** - Memosmart: One capsule twice daily after meals (for 2 months). - Phenibut 250mg: Half tablet twice daily until 7 PM (for 2 months). - B-complex: One vial daily (started 20 days ago). - Duomag: One capsule every evening after meals (for 2 months). **Current psychiatric medications (recently reduced by psychiatrist):** - Rispaxol 2mg: One tablet once a day at 10 AM after breakfast. - Neurolepsin 400mg: Half tablet at 9 PM. - Tizercine 25mg: One tablet at 9 PM. - Noxium injection: Frequency not specified. **New heart medications prescribed today:** - Nolpaza 20mg: Once each morning before meals (for 1 month). - Concor 5mg: Once daily at 10 AM; pulse to be monitored. - Aspirin Cardio 100mg: Once daily post-lunch. - Prestans 10/10mg: Once daily at 10 AM; blood pressure monitoring advised. - Physiotens 0.4mg: Once daily at 8 PM; blood pressure to be monitored. ## Queries 1. **Could the symptoms indicate neuroleptic malignant syndrome?** The patient's prolonged use of antipsychotics coupled with recent strokes may have resulted in this stuporous condition. 2. **Are there harmful interactions among his medications?** Concerns particularly focus on: - The combination of Phenibut and Zopiclone. - The use of multiple antipsychotics concurrently. - New heart medications interacting with ongoing psychiatric treatments. 3. **Is there a risk to the liver’s capacity to metabolize these medications** due to cirrhosis? 4. **Is immediate hospitalization warranted?** Neurologists and psychiatrists suspect medication-induced issues but have refrained from hospital admission due to the patient's non-acute status. 5. **Should we halt the new cardiac medications** until psychiatric medication levels are stabilized? ## Additional Points - The patient is compliant with medication without any overdose noted. - A 24-hour Holter monitor test returned normal results. - Multiple specialists (neurologist, psychiatrist, cardiologist) suspect a medication-related origin for current issues. - While currently conscious, the patient appears profoundly sedated. - Family members express deep concern regarding the sudden alteration in mental condition. **We seek insights on medication management and whether this situation necessitates urgent medical attention.**
Answers (1)
8/22/2025, 9:21:27 AM
OpenHealth AI
Main Points
The symptoms you've described could indeed suggest neuroleptic malignant syndrome (NMS) or another medication-related issue. Given the complex medication regimen and history of liver cirrhosis, there's a need for careful assessment and possibly urgent medical intervention.
Explanation
Neuroleptic Malignant Syndrome is a rare but serious reaction often associated with antipsychotic medications, leading to symptoms like extreme drowsiness, altered mental status, muscle rigidity, and autonomic instability. While muscle rigidity isn't clearly present in your case, the extreme sedation, episodes resembling "freezing," and altered consciousness are concerning.
Additionally, the potential harmful interactions in the patient's medications, especially given the liver cirrhosis which can impair drug metabolism, raise significant concerns. Certain combinations, such as Phenibut with Zopiclone or multiple antipsychotics, can increase sedation and confusion, further complicating the patient's current state.
Next Steps
-
Immediate Medical Assessment: Given the severity of symptoms, such as extreme drowsiness and semi-consciousness, seek urgent medical attention. If possible, contact the prescribing physicians immediately to discuss the situation. Notification may involve a psychiatrist and/or neurologist, who need to evaluate medication effects.
-
Medication Review and Adjustment: Upon consultation with medical professionals, a thorough review of all medications should be conducted. They may consider:
- Reducing or discontinuing sedative medications (e.g., Zopiclone, Phenibut).
- Monitoring and potentially adjusting antipsychotic doses to minimize any risks of NMS.
-
Liver Function Monitoring: Continuous monitoring of liver function tests should be conducted, especially given the cirrhosis, to ensure the liver can handle the medication load, and modifications can be made as needed.
-
Family Support: Engage family members in discussions about the patient’s health, symptoms, and care plan. Their observations about changes in the patient's awareness and behavior are valuable.
-
Avoid Further Medication Changes: Until assessed by a healthcare professional, avoid any changes in medication without professional guidance, especially the new cardiac medications or psychiatric treatments that may need stabilization first.
It’s crucial to prioritize patient safety and ensure that they are closely monitored so appropriate interventions can follow. Immediate action is recommended to better understand the cause of these alarming symptoms and to make any necessary adjustments quickly.
Related Questions
28-Year-Old Male Experiencing Scalp Sensations Post-Amitriptyline Treatment
I am a 28-year-old man in generally good health, without any cardiac concerns. Approximately a month ago, I encountered intense pain localized to one side of my head, which was unresponsive to paracetamol. However, a single dose of a migraine treatment provided substantial relief. Following that, I began a regimen of amitriptyline, starting at a nightly dose of 10 to 25 mg. While my head pain has diminished significantly—by about 90 to 95%—I now experience occasional uncomfortable sensations on my scalp. These feelings include pins and needles, a cooling sensation, and some crawling feelings near my hairline and ears. There are fleeting moments where I feel brief throbs lasting a second, but I do not have any persistent headaches. To clarify, I do not experience any of the following: - Nausea - Weakness in my limbs - Numbness - Changes in my vision - Coordination difficulties - Seizures The symptoms I have are transient, shifting around and often intensifying when I become conscious of them or as the day progresses. I would like to know: Is it common to experience these sensations during the recovery stage following episodes of neuralgia or migraine-like discomfort? Additionally, could the amitriptyline potentially be causing these temporary paresthetic sensations? I am seeking some reassurance or advice on what is typically observed during this healing process. Thank you.
7-Month-Old Child with Abernethy Malformation - Exploring Treatment Options
# 7-Month-Old Child with Abernethy Malformation - Exploring Treatment Options ## [7-Month-Old] Identified with Abernethy Malformation (Congenital Portosystemic Shunt) - Treatment Methods? **Age:** 7 months **Gender:** Female **Height:** Age-appropriate **Weight:** Currently 9 kg, was 2.8 kg at birth **Ethnicity:** Asian **Duration of Symptoms:** Present since birth **Location:** Uzbekistan **Pre-existing Health Issues:** Abernethy malformation (congenital portosystemic shunt), liver hemangiomas, chronic jaundice, anemia **Current Treatments:** Supportive management --- ## INITIAL PRESENTATION (June 2025 - July 2025) Our daughter arrived on **June 27, 2025**, presenting with: - Birth weight: **2.8 kg** - Marked jaundice (yellowing of skin and sclera) - Pale or clay-colored stools - **Bilirubin level: 245 μmol/L** (typically <20) An immediate ultrasound indicated multiple liver anomalies, initially thought to be hemangiomas. --- ## FIRST COMPREHENSIVE ASSESSMENT (August 1, 2025 - 1 Month Old) ### Multislice Computed Tomography (MSCT) with 3-Phase Contrast (August 1, 2025): **RESULTS:** - **Portocaval shunt size: 9.9 mm** (blood bypassing the liver into the inferior vena cava) - **Arteriovenous shunt size: 4.4 mm** - **Portal vein size: 6.1 mm** (patent) - **Three nodular cystic lesions** located in the perivascular area, with largest measuring 11.6×20.7 mm, enhancing during the venous phase - Liver features a heterogeneous architecture, exhibiting irregular enhancement - Gallbladder appears elongated and slightly enlarged - Other abdominal organs exhibit normal findings **RADIOLOGIST’S ASSESSMENT:** "Congenital portosystemic shunt indicative of Abernethy malformation; less likely arteriovenous malformation (AVM); cannot dismiss the possibility of localized liver lesions." **ADVICE:** Seek consultations with an abdominal and vascular surgeon. ### Blood Tests (August 1, 2025): **Complete Blood Count:** - WBC: 10.44 × 10⁹/L (normal range) - **RBC: 2.1 × 10¹²/L** (LOW - indicating severe anemia) - **Hemoglobin: 69 g/L** (CRITICALLY LOW; normal is 117-166) - Platelets: 403 × 10⁹/L (elevated) **Biochemistry Analysis:** - Urea: 1.80 mmol/L (normal) - Creatinine: 33.4 μmol/L (normal) - **ALT: >1000 IU/mL** (EXTREMELY HIGH - severe liver dysfunction) --- ## FOLLOW-UP IMAGING (December 16, 2025 - 5.5 Months Old) ### Liver Ultrasound: **RESULTS:** - Right lobe: 64 mm, left lobe: 43 mm - Liver capsule appears irregular and vague - **Parenchyma: heterogeneous, showing 7 hypo-isoechoic nodules** (sizes range from 11.5×10.7 mm to 17.6×15.4 mm) - Capsule features uneven contours - Blood flow noted during Doppler examination - No dilation in intrahepatic bile ducts - **Portal vein: 3.9 mm** (decreased from 6.1 mm - indicating improvement) - Common bile duct: 1.4 mm - Gallbladder: measures 43.7×9.2 mm (pear-shaped, wall thickness 2.0 mm, homogeneous, free of stones) **ULTRASOUND ASSESSMENT:** "Presence of liver volumetric formations (specifically liver hemangiomas)." --- ## LATEST MSCT (February 6, 2026 - 7 Months Old) ### MSCT with 3-Phase Contrast: **FINDINGS:** - Liver remains normal in size, but shows heterogeneous structure with uneven contrast enhancement - **Portocaval shunt: 9.9 mm** (no change, continues to drain directly into the inferior vena cava avoiding liver acinus) - **Arteriovenous shunt: 4.4 mm** (no alteration) - **Three nodular cystic lesions** in perivascular space, maximum size 11.6×20.7 mm, enhancing in the venous phase - **Portal vein: 6.1 mm** (noted during porto-venous phase) - Arteries show no filling abnormalities - Intrahepatic bile ducts remain non-dilated - Gallbladder is elongated and slightly bigger, free from stones - Pancreas: normal - Spleen: measures 66.9×38.5 mm (not enlarged), splenic vein is 3.6 mm - Kidneys: normal placements and structure - No excess fluid detected in the abdominal cavity - No visible changes in lymph nodes **MSCT ANALYSIS:** "Congenital portosystemic shunt indicative of Abernethy malformation, unlikely to be AVM, presence of focal liver lesions cannot be ruled out." **RECOMMENDATION:** Engage with an abdominal and vascular surgeon. --- ## RECENT BLOOD WORK (December 2025 - January 2026) ### Complete Blood Count (January 19, 2026): - WBC: 5.8 × 10⁹/L (SHOWS IMPROVEMENT) - **RBC: 2.93 × 10¹²/L** (IMPROVED but still low) - **Hemoglobin: 72 g/L** (SHOWS IMPROVEMENT but still low) - Platelets: 223 × 10⁹/L (BACK TO NORMAL) - Neutrophils: 30.0% - Lymphocytes: 64.8% - Monocytes: 4.6% ### Biochemistry (January 28, 2026): - Total protein level: 67 g/L (slightly deficient) - Creatinine: 20.7 μmol/L - **Total Bilirubin: 242 μmol/L** (STILL HIGH - unchanged) - **Direct Bilirubin: 142 μmol/L** (VERY HIGH) - **ALT: 50 IU/mL** (DRASTICALLY LOWER from >1000!) --- ## OVERVIEW OF PROGRESS OVER 6 MONTHS | Parameter | August 2025 | January 2026 | Change | |------------------|-------------|---------------|--------------------------| | **Hemoglobin** | 69 g/L | 72 g/L | ↗ Slight improvement | | **RBC** | 2.1 | 2.93 | ↗ Improved | | **ALT** | >1000 | 50 | ✓✓ MAJOR IMPROVEMENT | | **Bilirubin** | 245 | 242 | → Unchanged (still elevated) | | **Portal vein** | 6.1 mm | 3.9 mm (US) | ↗ Decreased | | **Platelets** | 403 | 223 | ↘ Normalized | | **Shunt size** | 9.9 mm | 9.9 mm | → No Change | --- ## CURRENT SITUATION (February 2026 - 7 Months Old) - **Weight:** 9 kg (good growth rate in spite of condition) - **Jaundice:** Continues to be present (yellow skin) - **Stools:** Remain pale/clay-colored - **Development:** Achieving appropriate milestones - **Energy:** Appears to have a good energy level - **Feeding:** Normal appetite --- ## QUESTIONS FOR r/AskDocs We have been informed this is **Type 2 Abernethy malformation** (portal vein present). **Three treatment avenues have been proposed:** ### Option 1: **Endovascular Coil Embolization** (minimally invasive approach) - A catheter is inserted via the leg vein to access the shunt and deploy coils/plugs to close the abnormal vessels - Pros: No surgical incision, minimal discomfort, short hospital stay (2-4 days), no scars, enhanced safety - Duration: 1-2 hours - Recovery: 2-4 weeks for jaundice to show improvement ### Option 2: **Open Surgical Intervention** - An incision in the abdomen to ligate abnormal vessels and redirect blood to the liver - Pros: Direct visualization, effective results - Cons: Surgical scar, longer recovery time (7-14 days in hospital) - Duration: 2-4 hours ### Option 3: **Liver Transplantation** - We have been advised this is not necessary as the portal vein is functional and liver health is improving. --- ## SPECIFIC QUESTIONS TO CONSIDER: 1. **With a functional portal vein (6.1 mm) and improving liver function (ALT normalized), is it advisable to pursue endovascular closure as the preferred treatment?** 2. **Despite ALT levels improving, the bilirubin remains consistently high (242). Should this be a cause for concern? Is there a prospect for it to normalize post shunt closure?** 3. **Are the hemangiomas/nodules (11.6×20.7 mm) linked to the shunt? Will they likely resolve following shunt repair?** 4. **How urgent is the proposed intervention? Is immediate action required, or is there flexibility to wait a few months?** 5. **What complications should we be vigilant for during the waiting period?** 6. **Regarding endovascular closure - what is the average success rate for infants aged 7 months? Are there concerns regarding the shunt size (9.9 mm)?** 7. **The measurement of the portal vein has shown improvement from 6.1 mm to 3.9 mm; should this be perceived as a positive sign or a reason for concern?** 8. **Are there special directives (diet modifications, medications) we should consider while awaiting the procedure?** 9. **Post-procedure, how long should we expect it might take for:** - Normalization of bilirubin levels? - Return of stool color to normal? - Resolution of jaundice? - Regression of hemangiomas? 10. **Can you recommend any specialized centers for pediatric Abernethy malformation treatments? We are located in Uzbekistan but are prepared to travel (to Turkey, Russia, South Korea, etc.)** --- ## ADDITIONAL INFORMATION - No family history of hepatic diseases - Pregnancy and delivery were normal - No additional congenital defects identified - Immunizations up to date - No history of bleeding disorders - No signs indicative of encephalopathy - Child is alert and engaged --- **I can supply actual MSCT images and comprehensive lab reports if they would be of assistance.** We sincerely appreciate any insights you can provide. We are striving to make the most informed decision regarding our daughter’s care and highly value expert medical opinions. **TL;DR:** 7-month-old diagnosed with Abernethy Type 2 malformation (9.9 mm portocaval shunt, patent portal vein). Liver functionality is improving (normalized ALT) while bilirubin remains elevated (242). Evaluating options between endovascular coil embolization and open surgery. Seeking expert advice on optimal treatment strategy and timing.
Strange Stomach Sensation Leading to Waking Up
Greetings. I'm a 36-year-old male, standing at 172 centimeters and weighing 90 kilograms. I don't take any medications, nor do I smoke. I've been living with diastasis recti for several years now, and I may also have irritable bowel syndrome (IBS). Additionally, I deal with fatty liver and kidney stones, though I assume these last two conditions are not related to my current concern. Occasionally, I experience a peculiar sensation that jolts me awake; it feels like a quick pulsing in my stomach. I’ve noticed it tends to affect the left side when I’m lying on my left side and the right side when on my right. Remarkably, it can occur even when I’m on my back. This strange feeling often escalates into a surge that fully rouses me. Alongside this, I sometimes feel prickling sensations throughout my body and fleeting lightheadedness. When this sensation disturbs my sleep while I’m turned to my side, shifting onto my back or the opposite side might alleviate it, but not always. In instances where I awaken while lying on my back, I discovered that gently pressing my hands on either side of my stomach can help, as can rising to a sitting or standing position. However, during my last two episodes—one a couple of weeks ago and another tonight—those techniques weren’t effective right away, which made me feel a bit anxious, prompting me to seek advice. Does anyone have insight into what might be going on? By the way, I’ve undergone routine ultrasound examinations of my abdomen by two different physicians during check-ups, both of whom assured me that everything appears normal, including my abdominal aorta and internal organs. They didn’t identify any issues at that time.
Understanding Tuberculosis Exposure Risk
A 26-year-old male, who neither drinks alcohol nor smokes, seeks to understand the implications of exposure to tuberculosis (TB). As an anesthesia technician, I became concerned after I encountered a TB-positive patient about a month ago. I had to enter the patient’s room several times to perform blood gas tests. On my first entry, I mistakenly wore my N95 mask incorrectly due to the hectic nature of attending to multiple rooms. From my research, it appears that TB is quite transmissible; direct exposure can pose a serious risk of infection. Transmission usually requires prolonged contact with an infected individual, particularly in a close or face-to-face setting. In this case, the patient was lying face down and appeared to be sleeping when I entered. I have already undergone testing for TB, but I am eager to deepen my understanding of the risks involved in these situations.
Challenges with Appetite and Discomfort While Eating — Difficulty in Gaining Weight
As an 18-year-old male, I find that I become satisfied after consuming rather minimal amounts of food. This situation presents a considerable challenge, particularly since I only need to have a standard breakfast, lunch, or dinner to feel completely satiated for the remainder of the day. My goal of increasing my weight has made this issue even more complicated. When I limit myself to one meal per day, I often face weight loss or an uncomfortable sensation of fullness that leaves me feeling sluggish. Opting for two meals makes me feel excessively bloated, distracting me from my daily responsibilities. Moreover, I suffer from an unusual issue with my throat, where almost any food I consume causes discomfort, as detailed in the list below. I have contemplated focusing on having just lunch while continuing my weightlifting regimen to maintain my current weight and gradually build muscle. What advice could you offer? Could there be an underlying cause for these symptoms? Lastly, would it be wise for me to consult a healthcare professional? Foods That Cause Discomfort: Bread, flour, pizza, fruits, sugary or starchy items, seed oils, chips, and essentially everything else. Foods That Are Tolerable: Rice, salads, chicken, fish, and vegetables. Overall Symptoms Include: * Quick satiety after normal meals * Challenges in gaining weight * Bloated and lethargic sensations when consuming more than one meal * Persistent throat sensitivity to a wide variety of foods